# US 2019/0314440 A1 · Composition for preventing or treating diseases caused by caffeine abuse including evodia officinalis extract or evodiamine as active ingredient

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314440 A1
- Document ID: US20190314440A1
- Status: Published application
- Kind: A1
- Application number: 16/466,484
- Filed: 2017-12-01
- Published: 2019-10-17
- Earliest claimed: 2016-12-06
- Assignees: Kabushiki Kaisha SG; Research & Business Foundation Sungkyunkwan University
- Applicants: Sg Corporation; Research & Business Foundation Sungkyunkwan University
- Inventors: Choon Gon JANG
- Web page: https://patentgrep.com/patent/US20190314440A1

## CPC

- A61K 36/754: Evodia
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/407: condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/08: for nausea, cinetosis or vertigo; Antiemetics
- A61P 1/12: Antidiarrhoeals
- A61P 25/30: for treating abuse or dependence
- A61K 2236/33: involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition which is for preventing or treating caffeine abuse and includes evodiamine or Evodia officinalis extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine abuse treatment method and a health functional food composition including Evodia officinalis extract or evodiamine.

## Claims

### Claim 1

A pharmaceutical composition including evodiamine or an Evodia officinalis extract as an active ingredient for preventing or treating a disease caused by caffeine abuse.

### Claim 2 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the Evodia officinalis extract is extracted using one or more types of solvents selected from water and alcohols having 1 to 4 carbon atoms.

### Claim 3 (depends on 1)

The pharmaceutical composition according to claim 1, wherein the disease is selected from the group consisting of insomnia, diarrhea, excitement, headaches, a lack of concentration, nausea, vomiting, depression, anxiety, hand tremors and muscle pain, which are induced by caffeine administration.

### Claim 4 (depends on 1)

A method of preventing or treating a disease caused by caffeine abuse, which comprises administering the composition of claim 1 to a subject.

### Claim 5

A health functional food composition for preventing or improving a disease caused by caffeine abuse, which comprises evodiamine or an Evodia officinalis extract as an active ingredient.

### Claim 6 (depends on 1)

A use of the composition of claim 1 for preventing or treating a disease caused by caffeine abuse.

### Claim 7 (depends on 2)

A method of preventing or treating a disease caused by caffeine abuse, which comprises administering the composition of claim 2 to a subject.

### Claim 8 (depends on 3)

A method of preventing or treating a disease caused by caffeine abuse, which comprises administering the composition of claim 3 to a subject.

### Claim 9 (depends on 2)

A use of the composition of claim 2 for preventing or treating a disease caused by caffeine abuse.

### Claim 10 (depends on 3)

A use of the composition of claim 3 for preventing or treating a disease caused by caffeine abuse.
